662 related articles for article (PubMed ID: 17620004)
21. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by salmeterol of increased vascular permeability and granulocyte accumulation in guinea-pig lung and skin.
Whelan CJ; Johnson M
Br J Pharmacol; 1992 Apr; 105(4):831-8. PubMed ID: 1354536
[TBL] [Abstract][Full Text] [Related]
23. Effects of a range of beta2 adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells.
Scott MG; Swan C; Jobson TM; Rees S; Hall IP
Br J Pharmacol; 1999 Oct; 128(3):721-9. PubMed ID: 10516654
[TBL] [Abstract][Full Text] [Related]
24. Comparison of the anti-inflammatory properties of formoterol, salbutamol and salmeterol in guinea-pig skin and lung.
Whelan CJ; Johnson M; Vardey CJ
Br J Pharmacol; 1993 Oct; 110(2):613-8. PubMed ID: 7902175
[TBL] [Abstract][Full Text] [Related]
25. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.
Kanthakumar K; Cundell DR; Johnson M; Wills PJ; Taylor GW; Cole PJ; Wilson R
Br J Pharmacol; 1994 Jun; 112(2):493-8. PubMed ID: 7915610
[TBL] [Abstract][Full Text] [Related]
26. Chronic systemic administration of salmeterol to rats promotes pulmonary beta(2)-adrenoceptor desensitization and down-regulation of G(s alpha).
Finney PA; Donnelly LE; Belvisi MG; Chuang TT; Birrell M; Harris A; Mak JC; Scorer C; Barnes PJ; Adcock IM; Giembycz MA
Br J Pharmacol; 2001 Mar; 132(6):1261-70. PubMed ID: 11250877
[TBL] [Abstract][Full Text] [Related]
27. Control of cyclic AMP levels in primary cultures of human tracheal smooth muscle cells.
Hall IP; Widdop S; Townsend P; Daykin K
Br J Pharmacol; 1992 Oct; 107(2):422-8. PubMed ID: 1384913
[TBL] [Abstract][Full Text] [Related]
28. Effects of salmeterol on muscarinic inhibition of adenylyl cyclase in bovine trachealis cells.
Ethier MF; Dextradeur T; Schaefer OP; Madison JM
Life Sci; 2000 Oct; 67(22):2753-8. PubMed ID: 11105991
[TBL] [Abstract][Full Text] [Related]
29. Estimation of the efficacy and affinity of the beta 2-adrenoceptor agonist salmeterol in guinea-pig trachea.
Dougall IG; Harper D; Jackson DM; Leff P
Br J Pharmacol; 1991 Dec; 104(4):1057-61. PubMed ID: 1687365
[TBL] [Abstract][Full Text] [Related]
30. Examination of the role of inhibition of cyclic AMP in alpha 2-adrenoceptor mediated contractions of the porcine isolated palmar lateral vein.
Wright IK; Harling R; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Jan; 114(1):157-65. PubMed ID: 7712012
[TBL] [Abstract][Full Text] [Related]
31. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
32. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
34. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.
Kaur M; Holden NS; Wilson SM; Sukkar MB; Chung KF; Barnes PJ; Newton R; Giembycz MA
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L505-14. PubMed ID: 18586957
[TBL] [Abstract][Full Text] [Related]
35. Alpha 2-adrenoceptor-mediated inhibition of electrically evoked [3H]noradrenaline release from chick sympathetic neurons: role of cyclic AMP.
Boehm S; Huck S; Koth G; Drobny H; Agneter E; Singer EA
J Neurochem; 1994 Jul; 63(1):146-54. PubMed ID: 7515943
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological characterization of beta2-adrenoceptor in PGT-beta mouse pineal gland tumour cells.
Suh BC; Chae HD; Chung JH; Kim KT
Br J Pharmacol; 1999 Jan; 126(2):399-406. PubMed ID: 10077231
[TBL] [Abstract][Full Text] [Related]
37. Prostaglandin E(2) increases cyclic AMP and inhibits endothelin-1 production/secretion by guinea-pig tracheal epithelial cells through EP(4) receptors.
Pelletier S; Dubé J; Villeneuve A; Gobeil F; Yang Q; Battistini B; Guillemette G; Sirois P
Br J Pharmacol; 2001 Mar; 132(5):999-1008. PubMed ID: 11226130
[TBL] [Abstract][Full Text] [Related]
38. Adenosine-induced inhibition of basal endothelin-1 production from guinea-pig tracheal epithelial cells: a mechanism involving the release of cAMP.
Pelletier S; Battistini B; Sirois P
Pulm Pharmacol Ther; 1998; 11(2-3):237-42. PubMed ID: 9918763
[TBL] [Abstract][Full Text] [Related]
39. Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.
Bergendal A; Lindén A; Skoogh BE; Gerspacher M; Anderson GP; Löfdahl CG
Br J Pharmacol; 1996 Mar; 117(6):1009-15. PubMed ID: 8882590
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effects of cyclic AMP elevating agents on lipopolysaccharide (LPS)-induced microvascular permeability change in mouse skin.
Irie K; Fujii E; Ishida H; Wada K; Suganuma T; Nishikori T; Yoshioka T; Muraki T
Br J Pharmacol; 2001 May; 133(2):237-42. PubMed ID: 11350859
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
